00928 KING INTL INV
- 0.079
- +0.003+3.95%
KING INTL INV News
Imperial International Investment (00928.HK): Wong Ka-shing Appointed as Joint Company Secretary and Authorized Representative
Gelonghui, March 14 | Imperial International Investment (00928.HK) announced that Xu Hongqun has resigned as the company's joint company secretary and no longer serves as the company's authorized representative under section 3.05 of the Hong Kong Stock Exchange Limited's securities listing rules and authorized representative to receive legal process documents and notifications in Hong Kong on behalf of the company under Part 16 of the Hong Kong Law Chapter 622 Companies Ordinance. Wong Ka-shing has been appointed as Joint Company Secretary, an authorized representative under the Listing Rules and an authorized representative to receive legal process documents and notifications in Hong Kong on behalf of the company under Part 16 of the Companies Ordinance, Chapter 622 of the Hong Kong Laws.
Imperial International Investment [00928] now reports HK$0.103, an increase of 17.05%
As of 09:47, Imperial International Investment [00928] reported HK$0.103, up HK$0.015 or 17.05% from yesterday's closing price, with a turnover of HK$0.41 million. Today's high price was HK$0.103 and the lowest price was HK$0.103. Based on yesterday's closing price, the 10-day average price was HK$0.09, and the 50-day average price was HK$0.08. The current price-earnings ratio was -5.15 times, and the 14-day strong and weak index reported 47.89.
Imperial International Investment [00928] now reports HK$0.099, an increase of 12.50%
As of 09:58, Imperial International Investment [00928] reported HK$0.099, up HK$0.011 or 12.50% from yesterday's closing price, with a turnover of HK$0.2 million. Today's high price was HK$0.099 and the lowest price was HK$0.099. Based on yesterday's closing price, the 10-day average price was HK$0.09, and the 50-day average price was HK$0.08. The current price-earnings ratio was -5.15 times, and the 14-day strength and weakness index was 50.00.
King International Investment Redesignates Co-Chairman as Chairman
King International Investment (HKG:0928) has redesignated co-chairman Wang Mengyao as its chairman effective today, Friday. Wang is currently the executive director of the education software products
Imperial International Investment (00928.HK): Wang Mengyao re-appointed as Chairman of the Board
Gelonghui, January 19, 丨 Imperial International Investment (00928.HK) issued an announcement. Wang Mengyao has been reassigned as the chairman of the company's board of directors, effective January 19, 2024.
King International Investment Shareholders to Vote Jan. 31 on Share Consolidation
Shareholders of King International Investment (HKG:0928) will meet Jan. 31 to vote on its proposed 5-for-1 share consolidation scheme, according to a Wednesday filing. Under the scheme, five shares at
King International Investment Limited (HKG:928) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
King International Investment Limited (HKG:928) shares have had a really impressive month, gaining 30% after a shaky period beforehand. Not all shareholders will be feeling jubilant, since the shar
King International Investment Names, Redesignates Co-Chairmen
King International Investment (HKG:0928) has hired Wang Mengyao and redesignated Liu Mingqing as co-chairmen of the company effective today, Thursday. Wang is currently an executive director, while Li
Imperial International Investment (00928.HK) appoints Wang Mengyao as Co-Chairman of the Board
Gelonghui, December 28, 丨 Imperial International Investment (00928.HK) announcements are effective from December 28, 2023:1. Mr. Wang Mengyao has been appointed as the co-chairman of the company's board of directors; 2. Mr. Liu Mingqing has been reassigned as co-chairman of the company's board of directors; and 3. Mr. Lu Xingwu has been appointed as the company's executive director.
Imperial International Investment (00928.HK) plans to sell 65% of Beijing Lianhe Health Management's shares for 23.6 million yuan
Gelonghui, December 22|Imperial International Investment (00928.HK) announced that on December 18, 2023, the seller (a wholly-owned subsidiary of the company) signed a sale agreement with the buyer. Based on this, the company agreed to sell sales rights to the buyer at a total cost of RMB 23.6 million. Sales rights account for 65% of the registered capital of the target company, Beijing Lianhe Health Management Co., Ltd. Target Group is mainly engaged in the development of major health markets in China, such as intelligent medical examinations, distribution of medical supplies and equipment, Internet medical technology, and medical research and development for public health care in rural areas. The director believed that the sale was superior to that
Lianhe Healthcare (00928.HK): Liu Mingqing appointed as Chairman of the Board
Gelonghui on December 19丨Lianhe Healthcare (00928.HK) announced that the following changes will take effect from December 18, 2023: Liu Mingqing has been appointed as the company's board chairman; Long Jinbo has been appointed as the company's executive director; Lou Tao has been appointed as the company's independent non-executive director; and Zhong Yulin has been appointed as the company's joint company secretary.
Life Healthcare Changes Name to King International Investment
Life Healthcare Group (HKG:0928) changed its English name to King International Investment Limited effective Nov. 24. The regulatory documents confirming the name change were received Nov. 24 in the C
Renhe Healthcare (00928.HK) changed its name to “Imperial International Investment Co., Ltd.”
Gelonghui announced on December 15: Lianhe Healthcare (00928.HK), the board of directors is pleased to announce that the company's English name has been changed from “Life Healthcare Group Limited” to “King International Investment Limited”, and that the company's Chinese dual foreign language name has been changed from “Lianhe Healthcare Group Co., Ltd.” to “Imperial International Investment Co., Ltd.”, all effective from November 24, 2023.
The stock abbreviation of Lianhe Healthcare (00928) will be changed to “Imperial International Investment”
Lotus Medical (00928) announced that the English name of the company has changed from “Life Healthcare...
Life Healthcare Raises HK$9.5 Million From Share Sale
Life Healthcare Group (HKG:0928) has completed the placement of 147.9 million new shares to three subscribers at HK$0.065 apiece to raise HK$9.5 million in net proceeds. The shares represent 8% of the
LIFE HEALTHCARE: Interim Report 2023
Life Healthcare Group Proposes 5-For-1 Share Consolidation Scheme; Shares Slide 8%
Life Healthcare Group (HKG:0928) directors proposed to carry out a 5-for-1 share consolidation scheme, under which five shares at HK$0.05 apiece will be consolidated into one share at HK$0.25 apiece,
Selected Gelonghui Announcements (Hong Kong Stocks) | China Overseas Development (00688.HK) November contract property sales amount is approximately $22,945 billion
[Today's focus] China Overseas Development (00688.HK) November contract property sales amount is about 22,945 billion yuan, China Overseas Development (00688.HK) announced that in November 2023, contract property sales of China's overseas series companies were about RMB 22,945 billion; the corresponding sold floor area was about 967,900 square meters. From January to November 2023, the cumulative contract property sales amount of China's overseas series companies was about RMB 287.028 billion, and the corresponding cumulative sales floor area was about 12,373,400 square meters, according to the respective figures
Lianhe Healthcare (00928.HK) proposed a “5 in 1” merger, and the trading unit for each lot will be changed to 10,000 shares
On December 6, Gelonghui Healthcare (00928.HK) issued an announcement. The board of directors proposed a share merger and proposed a “5 in 1” consolidated shares. The board of directors recommended that each lot traded on the Stock Exchange be changed from 20,000 existing shares to 10,000 consolidated shares after the share consolidation takes effect.
Life Healthcare Group Returns to Attributable Profit in Fiscal H1
Life Healthcare Group (HKG:0928) returned to an attributable profit of HK$1.7 million, or HK$0.0011 per share, in the fiscal first half, from a loss of HK$1.3 million, or HK$0.0009 per share, in the y
Analysis
Price Target
No Data
